VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,439,813 | -77.4% | 153,662 | -40.9% | 0.00% | -100.0% |
| Q2 2023 | $6,372,796 | +3.1% | 259,796 | -2.2% | 0.00% | – |
| Q1 2023 | $6,179,488 | +246.6% | 265,556 | +276.9% | 0.00% | – |
| Q4 2022 | $1,783,090 | +95.1% | 70,450 | +48.5% | 0.00% | – |
| Q3 2022 | $914,000 | +5.1% | 47,440 | +38.7% | 0.00% | – |
| Q2 2022 | $870,000 | +5.3% | 34,195 | +6.4% | 0.00% | – |
| Q1 2022 | $826,000 | -93.0% | 32,132 | -88.7% | 0.00% | -100.0% |
| Q4 2021 | $11,876,000 | – | 283,646 | +28364500.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |